<?xml version="1.0" encoding="UTF-8"?>
<p>Cone bioassays after re-treatment with KO-Tab 123 showed that the curtains did not immediately recover to the 100% bioefficacy observed at baseline. At 1 month following re-treatment (January 2011), average mortality for 36 ITCs was 74.5% (range: 48%-94%). By 9-months following re-treatment (August 2011) average mortality from 9 tested ITCs was 97.2% (range: 87.5%-100%).</p>
